Y-mAbs Therapeutics (YMAB) PT Lowered to $8 at Morgan Stanley
Tweet
Share
E-mailGet Alerts YMAB Hot Sheet
Price: $8.61 --0%
Rating Summary:
5 Buy, 11 Hold, 2 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 11 | Down: 14 | New: 9
Rating Summary:
5 Buy, 11 Hold, 2 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 11 | Down: 14 | New: 9
Join SI Premium – FREE
Morgan Stanley analyst Michael Ulz lowered the price target on Y-mAbs Therapeutics (NASDAQ: YMAB) to $8.00 (from $17.00) while maintaining a Equalweight rating.
You May Also Be Interested In
- Adyen NV (ADYEN:NA) (ADYYF) PT Raised to EUR1,230 at KeyBanc
- Volkswagen AG (VOW:GR) (VWAGY) PT Lowered to EUR120 at RBC Capital
- Hormel Foods (HRL) PT Raised to $26 at JPMorgan
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
